Acute kidney injury in acute liver failure: a review

References

• Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology 47(4), 1401–1415 (2008).
   PubMed Web of Science ®Google Scholar
• Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 376(9736), 190–201 (2010).
   PubMed Web of Science ®Google Scholar
• Ostapowicz G, Fontana RJ, Schiodt FV et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Inter. Med. 137(12), 947–954 (2002).
   PubMed Web of Science ®Google Scholar
• Craig DG, Lee A, Hayes PC, Simpson KJ. Review article: the current management of acute liver failure. Aliment. Pharmacol. Ther. 31(3), 345–358 (2010).
   PubMedGoogle Scholar
• Laleman W, Verbeke L, Meersseman P et al. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev. Gastroenterol. Hepatol. 5(4), 523–537 (2011).
   PubMed Web of Science ®Google Scholar
• Lisman T, Caldwell SH, Burroughs AK et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J. Hepatol. 53(2), 362–371 (2010).
   PubMed Web of Science ®Google Scholar
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20(6), 864–874 (1992).
   PubMed Web of Science ®Google Scholar
• Lee A. AASLD practice guidelines: Acute Liver Failure. AASLD practice guidelines: Acute Liver Failure 2011.
   Google Scholar
• Awad SS, Swaniker F, Bartlett RH. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis. Z. Gastroenterol. 39( Suppl. 2), 22–23 (2001).
   PubMedGoogle Scholar
• Betrosian AP, Agarwal B, Douzinas EE. Acute renal dysfunction in liver diseases. World J. Gastroenterol. 13(42), 5552–5559 (2007).
   PubMed Web of Science ®Google Scholar
• O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97(2), 439–445 (1989).
   PubMedGoogle Scholar
• O'Riordan A, Brummell Z, Sizer E et al. Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol. Dial. Transplant. 26(11), 3501–3508 (2011).
   PubMedGoogle Scholar
• Leithead JA, Ferguson JW, Bates CM et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 58(3), 443–449 (2009).
   PubMed Web of Science ®Google Scholar
• Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11(2), R31 (2007).
   PubMed Web of Science ®Google Scholar
• Wong F, Nadim MK, Kellum JA et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60(5), 702–709 (2011).
   PubMed Web of Science ®Google Scholar
• Fagundes C, Barreto R, Guevara M et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J. Hepatol. 59(3), 474–481 (2013).
   PubMed Web of Science ®Google Scholar
• Yong K, Dogra G, Boudville N, Pinder M, Lim W. Acute kidney injury: controversies revisited. Int. J. Nephrol. 2011, 762634 (2011).
   PubMedGoogle Scholar
• Brochard L, Abroug F, Brenner M et al. An official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of Acute Renal Failure in the ICU patient: an international consensus conference in intensive care medicine. Am. J. Respir. Crit. Care Med. 181(10), 1128–1155 (2010).
   PubMed Web of Science ®Google Scholar
• Moore K. Renal failure in acute liver failure. Eur. J. Gastroenterol. Hepatol. 11(9), 967–975 (1999).
   PubMedGoogle Scholar
• Martin-Llahi M, Guevara M, Torre A et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 140(2), 488–496 e484 (2011).
   PubMed Web of Science ®Google Scholar
• Mucino-Bermejo J, Carrillo-Esper R, Uribe M, Mendez-Sanchez N. Acute kidney injury in critically ill cirrhotic patients: a review. Ann. Hepatol. 11(3), 301–310 (2012).
   PubMed Web of Science ®Google Scholar
• Mayeux PR, Macmillan-Crow LA. Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. Pharmacol. Ther. 134(2), 139–155 (2012).
   PubMedGoogle Scholar
• Seeliger E, Sendeski M, Rihal CS, Persson PB. Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur. Heart J. 33(16), 2007–2015 (2012).
   PubMed Web of Science ®Google Scholar
• Urbschat A, Obermuller N, Haferkamp A. Biomarkers of kidney injury. Biomarkers 16 ( Suppl. 1), S22–S30 (2011).
   PubMed Web of Science ®Google Scholar
• Ytrebo LM, Sen S, Rose C et al. Systemic and regional hemodynamics in pigs with acute liver failure and the effect of albumin dialysis. Scand. J. Gastroenterol. 41(11), 1350–1360 (2006).
   PubMed Web of Science ®Google Scholar
• Anand R, Harry D, Holt S et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut 50(1), 111–117 (2002).
   PubMedGoogle Scholar
• Weigand K, Riediger C, Stremmel W, Flechtenmacher C, Encke J. Are heat stroke and physical exhaustion underestimated causes of acute hepatic failure? World J. Gastroenterol. 13(2), 306–309 (2007).
   PubMedGoogle Scholar
• Mazer M, Perrone J. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. J. Med. Toxicol. 4(1), 2–6 (2008).
   PubMedGoogle Scholar
• Lorz C, Justo P, Sanz AB, Egido J, Ortiz A. Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney Int. 67(2), 592–601 (2005).
   PubMedGoogle Scholar
• Linkermann A, De Zen F, Weinberg J, Kunzendorf U, Krautwald S. Programmed necrosis in acute kidney injury. Nephrol. Dial. Transplant. 27(9), 3412–3419 (2012).
   PubMed Web of Science ®Google Scholar
• Kaushal GP. Autophagy protects proximal tubular cells from injury and apoptosis. Kidney Int. 82(12), 1250–1253 (2012).
   PubMed Web of Science ®Google Scholar
• An J, Mehrhof F, Harms C et al. ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosis. J. Hepatol. 58(2), 297–305 (2013).
   PubMedGoogle Scholar
• Antoniades CG, Berry PA, Davies ET et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 44(1), 34–43 (2006).
   PubMed Web of Science ®Google Scholar
• Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment. Pharmacol. Ther. 31(10), 1064–1076 (2010).
   PubMed Web of Science ®Google Scholar
• Rosin DL, Okusa MD. Dangers within: DAMP responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 22(3), 416–425 (2011).
   PubMed Web of Science ®Google Scholar
• Dear JW, Simpson KJ, Nicolai MP et al. Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury. J. Immunol. 187(6), 3347–3352 (2011).
   PubMedGoogle Scholar
• Craig DG, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int. 31(8), 1127–1136 (2011).
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Jenkins RE, Dear JW et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J. Hepatol. 56(5), 1070–1079 (2012).
   PubMed Web of Science ®Google Scholar
• Shah N, De Oca MM, Jover-Cobos M et al. Role of toll-like receptor-4 in mediating multi-organ dysfunction in acetaminophen induced acute liver failure in mice. Liver Transpl. 19(7), 751–761 (2013).
   PubMedGoogle Scholar
• Hoet P, Haufroid V, Deumer G, Dumont X, Lison D, Hantson P. Acute kidney injury following acute liver failure: potential role of systemic cadmium mobilization? Intensive Care Med. 38(3), 467–473 (2012).
   PubMedGoogle Scholar
• Yap SC, Lee HT. Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthesiology 116(5), 1139–1148 (2012).
   PubMed Web of Science ®Google Scholar
• Lane K, Dixon JJ, Macphee IA, Philips BJ. Renohepatic crosstalk: does acute kidney injury cause liver dysfunction? Nephrol. Dial. Transplant. 28(7), 1634–1647 (2013).
   PubMed Web of Science ®Google Scholar
• Singh S, Hynan LS, Lee WM. Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig. Dis. Sci. 58(5), 1397–1402 (2013).
   PubMed Web of Science ®Google Scholar
• Olde Damink SW, Jalan R, Dejong CH. Interorgan ammonia trafficking in liver disease. Metab. Brain Dis. 24(1), 169–181 (2009).
   PubMed Web of Science ®Google Scholar
• Rama Rao KV, Jayakumar AR, Tong X, Curtis KM, Norenberg MD. Brain aquaporin-4 in experimental acute liver failure. J. Neuropathol. Exp. Neurol. 69(9), 869–879 (2010).
   PubMedGoogle Scholar
• Plauth M, Cabre E, Campillo B et al. ESPEN Guidelines on parenteral nutrition: hepatology. Clin. Nutr. 28(4), 436–444 (2009).
   PubMed Web of Science ®Google Scholar
• Perazella MA, Coca SG. Three feasible strategies to minimize kidney injury in 'incipient AKI'. Nat. Rev. Nephrol. 9(8), 484–490 (2013).
   PubMedGoogle Scholar
• Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39(2), 464–470 (2004).
   PubMedGoogle Scholar
• Zacharias M, Conlon NP, Herbison GP, Sivalingam P, Walker RJ, Hovhannisyan K. Interventions for protecting renal function in the perioperative period. Cochrane Database Syst. Rev (4), CD003590 (2008).
   Google Scholar
• Gordon AC, Russell JA, Walley KR et al. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 36(1), 83–91 (2010).
   PubMed Web of Science ®Google Scholar
• Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst. Rev 2, CD000567 (2013).
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 380(9843), 756–766 (2012).
   PubMed Web of Science ®Google Scholar
• Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int. Suppl. 41, S245–S251 (1993).
   PubMedGoogle Scholar
• Davenport A, Bouman C, Kirpalani A et al. Delivery of renal replacement therapy in acute kidney injury: what are the key issues? Clin. J. Am. Soc. Nephrol. 3(3), 869–875 (2008).
   PubMedGoogle Scholar
• Davenport A. Is there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int. Suppl. (72), S62–S66 (1999).
   Google Scholar
• Wu VC, Ko WJ, Chang HW et al. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes. J. Am. Coll. Surg. 205(2), 266–276 (2007).
   PubMedGoogle Scholar
• Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C. The first international consensus conference on continuous renal replacement therapy. Kidney Int. 62(5), 1855–1863 (2002).
   PubMedGoogle Scholar
• Network VNaRFT, Palevsky PM, Zhang JH et al. Intensity of renal support in critically ill patients with acute kidney injury. N. Engl. J. Med. 359(1), 7–20 (2008).
   PubMed Web of Science ®Google Scholar
• Kellum JA, Ronco C. Dialysis: results of RENAL--what is the optimal CRRT target dose? Nature reviews. Nephrology 6(4), 191–192 (2010).
   PubMedGoogle Scholar
• Honore PM, Jacobs R, Boer W et al. New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif. 33(1–3), 44–51 (2012).
   PubMedGoogle Scholar
• Stenbog P, Busk T, Larsen FS. Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange. Metab. Brain Dis. 28(2), 333–335 (2013).
   PubMed Web of Science ®Google Scholar
• Banares R, Nevens F, Larsen FS et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 57(3), 1153–1162 (2013).
   PubMed Web of Science ®Google Scholar
• Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif. Organs 26(2), 103–110 (2002).
   PubMedGoogle Scholar
• Saliba F, Camus C, Durand F et al. Randomised controlled multicentre trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure. Presented at: The 59th Annual meeting of the American Association for the Study of Liver Diseases. CA, USA, 31 October–4 November 2008.
   Google Scholar
• Cerda J, Tolwani A, Gibney N, Tiranathanagul K. Renal replacement therapy in special settings: extracorporeal support devices in liver failure. Semin. Dial. 24(2), 197–202 (2011).
   PubMedGoogle Scholar
• Rifai K, Ernst T, Kretschmer U et al. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif. 23(4), 298–302 (2005).
   PubMed Web of Science ®Google Scholar
• Pickkers P, Heemskerk S, Schouten J et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomised double-blind placebo-controlled trial. Crit. Care 16(1), R14 (2012).
   PubMed Web of Science ®Google Scholar
• Leithead JA, Ferguson JW, Bates CM, Davidson JS, Simpson KJ, Hayes PC. Chronic kidney disease after liver transplantation for acute liver failure is not associated with perioperative renal dysfunction. Am. J. Transplant. 11(9), 1905–1915 (2011).
   PubMedGoogle Scholar
• Barshes NR, Lee TC, Balkrishnan R, Karpen SJ, Carter BA, Goss JA. Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure. Transplantation 81(2), 195–201 (2006).
   PubMedGoogle Scholar
• Pakravan N, Simpson KJ, Waring WS, Bates CM, Bateman DN. Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit. Eur. J. Clin. Pharmacol. 65(2), 163–168 (2009).
   PubMed Web of Science ®Google Scholar
• Lines SW, Wood A, Bellamy MC, Lewington AJ. The outcomes of critically ill patients with combined severe acute liver and kidney injury secondary to paracetamol toxicity requiring renal replacement therapy. Renal. Failure 33(8), 785–788 (2011)
   PubMed Web of Science ®Google Scholar
• Bennett M, Dent CL, Ma Q et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin. J. Am. Soc. Nephrol. 3(3), 665–673 (2008).
   PubMed Web of Science ®Google Scholar
• Fagundes C, Pepin MN, Guevara M et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J. Hepatol. 57(2), 267–273 (2012).
   PubMed Web of Science ®Google Scholar
• Sirota JC, Walcher A, Faubel S et al. Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation. BMC Nephrol. 14, 17 (2013).
   PubMed Web of Science ®Google Scholar
• Coca SG, Parikh CR. Urinary biomarkers for acute kidney injury: perspectives on translation. Clin. J. Am. Soc. Nephrol. 3(2), 481–490 (2008).
   PubMed Web of Science ®Google Scholar
• Togel FE, Westenfelder C. Kidney protection and regeneration following acute injury: progress through stem cell therapy. Am. J. Kidney Dis. 60(6), 1012–1022 (2012).
   PubMed Web of Science ®Google Scholar